Product Code: SR112023A4392
Abstract
The global protein purification and isolation market size reached US$ 8.4 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 14.5 Billion by 2028, exhibiting a growth rate (CAGR) of 9.53% during 2022-2028.
Protein purification and isolation refer to a series of processes undertaken for isolating a type of protein from a complex mixture of cells, organisms, or tissues. These processes are mandatory for performing protein studies, which isolate, concentrate, stabilize, and remove impurities like nucleic acid, endotoxins, and viruses. They involve determining the initial material and maintaining a purification table to track the progress of the enzyme. They are primarily utilized for the classification of the function, structure, and interactions of the protein. Some of the commonly used methods of protein purification and isolation include affinity chromatography, immunoprecipitation, proteomics, or enzyme assay.
Protein Purification and Isolation Market Trends:
The burgeoning pharmaceutical industry across the globe represents one of the primary factors strengthening the growth of the market. Besides this, governing agencies of numerous countries are coming up with favorable initiatives to provide tax incentives, grants, and investment-friendly regulations to the pharmaceutical and biotechnology sector. These initiatives are positively influencing the manufacturers to engage in the research and development (R&D) activities for the development of novel drugs, which is significantly contributing to the market growth. Furthermore, there is a rise in the need for identifying new ligands and the development of purification kits that assist in the screening, preparing, purifying, and concentrating of protein samples. This is acting as another growth-inducing factor. Moreover, several technological advancements, including the introduction of magnetic and protein beads, ligand tagging systems, and automated analyzers, are creating a favorable market outlook. Other major factors like rising research initiatives in academic institutes for structural and functional proteomics, detailed kinetic analysis, and the increasing number of preclinical trials outsourced by drug development companies are anticipated to drive the market further.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global protein purification and isolation market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on technology, product, application and end user.
Breakup by Technology:
Ultrafiltration
Precipitation
Preparative Chromatography
Affinity Chromatography
Ion Exchange Chromatography
Reverse-Phase Chromatography
Hydrophobic Charge Induction Chromatography
Size Exclusion Chromatography
Electrophoresis
Gel Electrophoresis
Isoelectric Focusing Electrophoresis
Capillary Electrophoresis
Western Blotting
Dialysis and Diafiltration
Centrifugation
Breakup by Product:
Instruments
Consumables
Protein Purification Kits
Protein Purification Reagents
Prepacked Columns
Protein Purification Resins
Magnetic Beads
Others
Breakup by Application:
Drug Screening
Protein-Protein Interaction Studies
Biomarker Discovery
Target Identification
Disease Diagnostics and Monitoring
Protein Therapeutics
Breakup by End User:
Hospitals and Diagnostic Centers
Academic Research Institutes
Pharmaceutical and Biotechnology Companies
contract research organizations (CROs)
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Abcam plc, Agilent Technologies Inc., Bio-Rad Laboratories Inc., General Electric Company, Merck KGaA, Norgen Biotek Corp., Promega Corporation, Purolite, Qiagen N.V. and Thermo Fisher Scientific Inc.
Key Questions Answered in This Report:
- How has the global protein purification and isolation market performed so far and how will it perform in the coming years?
- What has been the impact of COVID-19 on the global protein purification and isolation market?
- What are the key regional markets?
- What is the breakup of the market based on the technology?
- What is the breakup of the market based on the product?
- What is the breakup of the market based on the application?
- What is the breakup of the market based on the end user?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the industry?
- What is the structure of the global protein purification and isolation market and who are the key players?
- What is the degree of competition in the industry?
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Protein Purification and Isolation Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Technology
- 6.1 Ultrafiltration
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
- 6.2 Precipitation
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
- 6.3 Preparative Chromatography
- 6.3.1 Market Trends
- 6.3.2 Key Segments
- 6.3.2.1 Affinity Chromatography
- 6.3.2.2 Ion Exchange Chromatography
- 6.3.2.3 Reverse-Phase Chromatography
- 6.3.2.4 Hydrophobic Charge Induction Chromatography
- 6.3.2.5 Size Exclusion Chromatography
- 6.3.3 Market Forecast
- 6.4 Electrophoresis
- 6.4.1 Market Trends
- 6.4.2 Key Segments
- 6.4.2.1 Gel Electrophoresis
- 6.4.2.2 Isoelectric Focusing Electrophoresis
- 6.4.2.3 Capillary Electrophoresis
- 6.4.3 Market Forecast
- 6.5 Western Blotting
- 6.5.1 Market Trends
- 6.5.2 Market Forecast
- 6.6 Dialysis and Diafiltration
- 6.6.1 Market Trends
- 6.6.2 Market Forecast
- 6.7 Centrifugation
- 6.7.1 Market Trends
- 6.7.2 Market Forecast
7 Market Breakup by Product
- 7.1 Instruments
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Consumables
- 7.2.1 Market Trends
- 7.2.2 Key Segments
- 7.2.2.1 Protein Purification Kits
- 7.2.2.2 Protein Purification Reagents
- 7.2.2.3 Prepacked Columns
- 7.2.2.4 Protein Purification Resins
- 7.2.2.5 Magnetic Beads
- 7.2.2.6 Others
- 7.2.3 Market Forecast
8 Market Breakup by Application
- 8.1 Drug Screening
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
- 8.2 Protein-Protein Interaction Studies
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
- 8.3 Biomarker Discovery
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
- 8.4 Target Identification
- 8.4.1 Market Trends
- 8.4.2 Market Forecast
- 8.5 Disease Diagnostics and Monitoring
- 8.5.1 Market Trends
- 8.5.2 Market Forecast
- 8.6 Protein Therapeutics
- 8.6.1 Market Trends
- 8.6.2 Market Forecast
9 Market Breakup by End User
- 9.1 Hospitals and Diagnostic Centers
- 9.1.1 Market Trends
- 9.1.2 Market Forecast
- 9.2 Academic Research Institutes
- 9.2.1 Market Trends
- 9.2.2 Market Forecast
- 9.3 Pharmaceutical and Biotechnology Companies
- 9.3.1 Market Trends
- 9.3.2 Market Forecast
- 9.4 contract research organizations (CROs)
- 9.4.1 Market Trends
- 9.4.2 Market Forecast
10 Market Breakup by Region
- 10.1 North America
- 10.1.1 United States
- 10.1.1.1 Market Trends
- 10.1.1.2 Market Forecast
- 10.1.2 Canada
- 10.1.2.1 Market Trends
- 10.1.2.2 Market Forecast
- 10.2 Asia-Pacific
- 10.2.1 China
- 10.2.1.1 Market Trends
- 10.2.1.2 Market Forecast
- 10.2.2 Japan
- 10.2.2.1 Market Trends
- 10.2.2.2 Market Forecast
- 10.2.3 India
- 10.2.3.1 Market Trends
- 10.2.3.2 Market Forecast
- 10.2.4 South Korea
- 10.2.4.1 Market Trends
- 10.2.4.2 Market Forecast
- 10.2.5 Australia
- 10.2.5.1 Market Trends
- 10.2.5.2 Market Forecast
- 10.2.6 Indonesia
- 10.2.6.1 Market Trends
- 10.2.6.2 Market Forecast
- 10.2.7 Others
- 10.2.7.1 Market Trends
- 10.2.7.2 Market Forecast
- 10.3 Europe
- 10.3.1 Germany
- 10.3.1.1 Market Trends
- 10.3.1.2 Market Forecast
- 10.3.2 France
- 10.3.2.1 Market Trends
- 10.3.2.2 Market Forecast
- 10.3.3 United Kingdom
- 10.3.3.1 Market Trends
- 10.3.3.2 Market Forecast
- 10.3.4 Italy
- 10.3.4.1 Market Trends
- 10.3.4.2 Market Forecast
- 10.3.5 Spain
- 10.3.5.1 Market Trends
- 10.3.5.2 Market Forecast
- 10.3.6 Russia
- 10.3.6.1 Market Trends
- 10.3.6.2 Market Forecast
- 10.3.7 Others
- 10.3.7.1 Market Trends
- 10.3.7.2 Market Forecast
- 10.4 Latin America
- 10.4.1 Brazil
- 10.4.1.1 Market Trends
- 10.4.1.2 Market Forecast
- 10.4.2 Mexico
- 10.4.2.1 Market Trends
- 10.4.2.2 Market Forecast
- 10.4.3 Others
- 10.4.3.1 Market Trends
- 10.4.3.2 Market Forecast
- 10.5 Middle East and Africa
- 10.5.1 Market Trends
- 10.5.2 Market Breakup by Country
- 10.5.3 Market Forecast
11 SWOT Analysis
- 11.1 Overview
- 11.2 Strengths
- 11.3 Weaknesses
- 11.4 Opportunities
- 11.5 Threats
12 Value Chain Analysis
13 Porters Five Forces Analysis
- 13.1 Overview
- 13.2 Bargaining Power of Buyers
- 13.3 Bargaining Power of Suppliers
- 13.4 Degree of Competition
- 13.5 Threat of New Entrants
- 13.6 Threat of Substitutes
14 Price Analysis
15 Competitive Landscape
- 15.1 Market Structure
- 15.2 Key Players
- 15.3 Profiles of Key Players
- 15.3.1 Abcam plc
- 15.3.1.1 Company Overview
- 15.3.1.2 Product Portfolio
- 15.3.1.3 Financials
- 15.3.1.4 SWOT Analysis
- 15.3.2 Agilent Technologies Inc.
- 15.3.2.1 Company Overview
- 15.3.2.2 Product Portfolio
- 15.3.2.3 Financials
- 15.3.2.4 SWOT Analysis
- 15.3.3 Bio-Rad Laboratories Inc.
- 15.3.3.1 Company Overview
- 15.3.3.2 Product Portfolio
- 15.3.3.3 Financials
- 15.3.3.4 SWOT Analysis
- 15.3.4 General Electric Company
- 15.3.4.1 Company Overview
- 15.3.4.2 Product Portfolio
- 15.3.4.3 Financials
- 15.3.4.4 SWOT Analysis
- 15.3.5 Merck KGaA
- 15.3.5.1 Company Overview
- 15.3.5.2 Product Portfolio
- 15.3.5.3 Financials
- 15.3.5.4 SWOT Analysis
- 15.3.6 Norgen Biotek Corp.
- 15.3.6.1 Company Overview
- 15.3.6.2 Product Portfolio
- 15.3.7 Promega Corporation
- 15.3.7.1 Company Overview
- 15.3.7.2 Product Portfolio
- 15.3.8 Purolite
- 15.3.8.1 Company Overview
- 15.3.8.2 Product Portfolio
- 15.3.9 Qiagen N.V.
- 15.3.9.1 Company Overview
- 15.3.9.2 Product Portfolio
- 15.3.9.3 Financials
- 15.3.9.4 SWOT Analysis
- 15.3.10 Thermo Fisher Scientific Inc.
- 15.3.10.1 Company Overview
- 15.3.10.2 Product Portfolio
- 15.3.10.3 Financials
- 15.3.10.4 SWOT Analysis